Ertapenem

SLC is commercializing and registering high quality API and Drug Product:
(In certain territories SLC will own our own license.)
  API FDF
Ertapenem
Ertapenem Sodium (Non-Sterile)
Ertapenem for Injection (Sterile Bulk)
Ertapenem Inj. 1g

Ertapenem for Injection is a new form of Carbapenem, which can be widely used on Gram-negative and Gram-positive anaerobes and aerobic.
Ertapenem Injection is indicated for the treatment of adult patients and pediatric patients (3 months of age and older) with the following moderate to severe infections caused by susceptible isolates of the designated microorganisms:
  • Complicated Intra-Abdominal Infections
  • Complicated Skin and Skin Structure Infections, Including Diabetic Foot Infections without Osteomyelitis
  • Community Acquired Pneumonia
  • Complicated Urinary Tract Infections Including Pyelonephritis
  • Acute Pelvic Infections Including Postpartum Endomyometritis, Septic Abortion and Post Surgical Gynecologic Infections
  • Prophylaxis of Surgical Site Infection Following Elective Colorectal Surgery
Instructions for Use in all patients
  • For Intravenous or Intramuscular Use
    DO NOT MIX OR CO-INFUSE Ertapenem Injection WITH OTHER MEDICATIONS.
    DO NOT USE DILUENTS CONTAINING DEXTROSE (α-D-GLUCOSE).
  • Ertapenem Injection may be administered by intravenous infusion for up to 14 days or intramuscular injection for up to 7 days. When administered intravenously, Ertapenem for Injection should be infused over a period of 30 minutes. Intramuscular administration of Ertapenem Injection may be used as an alternative to intravenous administration in the treatment of those infections for which intramuscular therapy is appropriate.

Treatment Regimen
  • 13 years of age and older
    The dose of Ertapenem Injection in patients 13 years of age and older is 1 gram.
  • 3 months to 12 years of age
    The dose of Ertapenem Injection in patients 3 months to 12 years of age is 15 mg/kg twice daily (not to exceed 1 g/day).


Download